Maximum quantity allowed is 999
请选择数量
CAS RN: 209216-23-9 | 產品號碼: E0899
Entecavir Monohydrate
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
補充產品訊息:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
| 產品號碼 | E0899 |
| 純度/分析方法 | >98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__1__2H__1__5N__5O__3·H__2O = 295.30 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
| 包裝和容器 | 200MG-Glass Bottle with Plastic Insert （閲覽圖片）, 50MG-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 209216-23-9 |
| 相關CAS RN | 142217-69-4 |
| Reaxys-RN | 14632881 |
| PubChem Substance ID | 253660820 |
| Merck Index(14) | 3595 |
| MDL編號 | MFCD09754448 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| Specific rotation [a]20/D | +34.0 to +38.0 deg(C=0.25, H2O)(calcd.on anh.substance) |
| Water | 4.0 to 9.0 % |
性質
| 熔點 | 259 °C(dec.) |
| 比旋光 [α]D | 36° (C=0.25,H2O) |
| Degree of solubility in water | 2.4 g/l |
| 溶解性（可溶於） | Dimethylformamide |
| 溶解性（微溶於） | Methanol |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H302 : Harmful if swallowed. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
運輸資料
| HS編碼* | 2933.99-000 |
Application
Cefdinir: A Third-Generation Cephalosporin More Active Against Gram-Positive Organisms
Entecavir (ETV or BMS-200475), a deoxyguanosine analog, is rapidly phosphorylated in vivo to the active intracellular 5'-triphosphate form that inhibits replication of hepatitis B virus (HBV) and shows reduced activity against other viruses, including HIV-1, influenza and herpes simplex viruses. Entecavir is a nucleoside reverse transcriptase inhibitor (NRTI). It inhibits reverse transcription in the viral replication process. (The product is for research purpose only.)
References
- BMS-200475, a novel carbocyclic 2'-deoxyguanosine analog with potent and selective anti-hepatitis B virus activity in vitro
- Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus
- Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro
- Potent efficacy of entecavir (BMS-200475) in a Duck model of hepatitis B virus replication
- Inhibition of hepatitis B virus polymerase by entecavir
- Entecavir: A review of its use in chronic hepatitis B
考研文獻
文章/手冊
TCIMail
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）